Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
about
Body mass index as a prognostic factor in patients with extranodal natural killer/T-cell lymphoma, nasal type.Impact of sarcopenia in the management of urological cancer patients.Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy.A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one.Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017.Chest computed tomography-derived low fat-free mass index and mortality in COPD.An analysis of the types of recently published research in the field of cachexia.Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.Muscle wasting and sarcopenia in heart failure and beyond: update 2017.Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines.Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer
P2860
Q37718504-A12241A8-AB6F-496B-8CAA-3D1809084304Q38749004-04E23B77-9E6B-4EA7-8434-0F0E6DC46FAEQ38789158-41FBAA6E-C17D-4047-81E5-5AE37741CB63Q40675622-6975BC07-3CF9-4018-8434-0D9FF4FEDAA7Q41470871-DD17E684-6B5D-4016-987E-845066801F3DQ46213438-3CD6B676-6E20-4DDD-A775-62CB65E746A1Q47307473-BC62BFAB-FF8F-4CCC-B5BD-615D5A51619FQ47568983-01418A11-F3EA-4CB3-8E54-A8990E72F2CAQ47648052-E09178CD-FFDD-4140-95A4-CB841E4642B4Q47797910-D660D3A5-9278-4C8F-A678-889EE01D664CQ49183956-31CDE199-A043-4BCF-94BC-A0A3C3ED0549Q55196969-B9D05E98-F23E-41AF-9C71-75FF1A0DB3B5Q57476138-4B4C89C6-9E7D-416D-9D71-608EF0358872Q59137542-F81ECBC3-FA14-4637-9B7B-108291DE5708
P2860
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prognostic impact of sarcopeni ...... , vincristine, and prednisone.
@ast
Prognostic impact of sarcopeni ...... , vincristine, and prednisone.
@en
type
label
Prognostic impact of sarcopeni ...... , vincristine, and prednisone.
@ast
Prognostic impact of sarcopeni ...... , vincristine, and prednisone.
@en
prefLabel
Prognostic impact of sarcopeni ...... , vincristine, and prednisone.
@ast
Prognostic impact of sarcopeni ...... , vincristine, and prednisone.
@en
P2093
P2860
P356
P1476
Prognostic impact of sarcopeni ...... , vincristine, and prednisone.
@en
P2093
Gyeong-Won Lee
Haa-Na Song
Hoon-Gu Kim
Hyang Rae Lee
Mi Jung Park
Myoung Hee Kang
Rock Bum Kim
Soon Il Lee
P2860
P304
P356
10.1002/JCSM.12115
P577
2016-04-12T00:00:00Z